Quick Answer
MedWellAI, Inc. reported Diluted EPS of $2.72 per share (loss) for fiscal year 2024.
MedWellAI, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$2.72 | +77.3% |
| 2023 | -$11.98 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | -$0.10 | -1100.0% | +23.1% |
| December 31, 2024 | -$0.13 | +0.0% | -1400.0% |
| March 31, 2024 | $0.01 | +101.1% | +107.7% |
| December 31, 2023 | -$0.13 | +81.4% | +85.2% |
| March 31, 2023 | -$0.88 | -576.9% | -25.7% |
| December 31, 2022 | -$0.70 | — | — |
| September 30, 2022 | $0.00 | — | +100.0% |
| March 31, 2022 | -$0.13 | -18.2% | — |
- MedWellAI, Inc. showed an increase of +77.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2024 period, MedWellAI, Inc.’s diluted eps has grown by 77.3% (from $11.98 per share (loss) to $2.72 per share (loss)).
- The most recent figure is from MedWellAI, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on September 30, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: